Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase
- PMID: 15447630
- PMCID: PMC1134735
- DOI: 10.1042/BJ20041330
Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase
Abstract
The gene for NAT (arylamine N-acetyltransferase) from Pseudomonas aeruginosa (panat) has been cloned from genomic DNA, and the gene product (PANAT) expressed as an N-terminal histidine-tagged protein in Escherichia coli and purified via nickel ion affinity chromatography. The specific activities of PANAT against a broad range of substrates have been investigated and compared with those of other prokaryotic NAT enzymes. For most arylamine substrates identified, PANAT exhibits in vitro specific activities typically one order of magnitude greater than those of recombinant NAT enzymes from Mycobacterium smegmatis or Salmonella typhimurium. Among the substrates of PANAT so far identified are the anti-tubercular drug isoniazid, 5-aminosalicylate (a drug used in the treatment of inflammatory bowel disease), as well as important environmental pollutants such as 3,4-dichloroaniline and 2-aminofluorene. As well as acetylating common NAT substrates, PANAT is unique among the prokaryotic NATs so far studied in acetylating the folate precursor 4-aminobenzoic acid and the folate catabolite 4-aminobenzoylglutamate. The recombinant protein has been expressed in sufficient quantity to allow protein crystallization, and we have subsequently determined the 1.95 A structure of PANAT by X-ray crystallography.
Figures





Similar articles
-
Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.J Bacteriol. 1999 Feb;181(4):1343-7. doi: 10.1128/JB.181.4.1343-1347.1999. J Bacteriol. 1999. PMID: 9973365 Free PMC article.
-
The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.J Mol Biol. 2002 May 10;318(4):1071-83. doi: 10.1016/S0022-2836(02)00141-9. J Mol Biol. 2002. PMID: 12054803
-
Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.Protein Expr Purif. 2003 Jan;27(1):75-84. doi: 10.1016/s1046-5928(02)00592-2. Protein Expr Purif. 2003. PMID: 12509987
-
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.Br J Pharmacol. 2014 Jun;171(11):2705-25. doi: 10.1111/bph.12598. Br J Pharmacol. 2014. PMID: 24467436 Free PMC article. Review.
-
Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.Biochem Soc Trans. 2003 Jun;31(Pt 3):615-9. doi: 10.1042/bst0310615. Biochem Soc Trans. 2003. PMID: 12773167 Review.
Cited by
-
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.Pharmacogenet Genomics. 2007 Jan;17(1):37-45. doi: 10.1097/01.fpc.0000236325.73186.2c. Pharmacogenet Genomics. 2007. PMID: 17264801 Free PMC article.
-
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.Protein Cell. 2010 Jan;1(1):82-95. doi: 10.1007/s13238-010-0006-1. Epub 2010 Mar 18. Protein Cell. 2010. PMID: 21204000 Free PMC article.
-
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16. Gut Microbes. 2024. PMID: 39150897 Free PMC article. Review.
-
Arylamine N-acetyltransferase responsible for acetylation of 2-aminophenols in Streptomyces griseus.J Bacteriol. 2007 Mar;189(5):2155-9. doi: 10.1128/JB.01708-06. Epub 2006 Dec 8. J Bacteriol. 2007. PMID: 17158669 Free PMC article.
-
The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.World J Microbiol Biotechnol. 2019 Oct 31;35(11):174. doi: 10.1007/s11274-019-2755-1. World J Microbiol Biotechnol. 2019. PMID: 31673919
References
-
- Upton A., Johnson N., Sandy J., Sim E. Arylamine N-acetyltransferases – of mice, men and microorganisms. Trends Pharmacol. Sci. 2001;22:140–146. - PubMed
-
- Evans D. A. N-acetyltransferase. Pharmacol. Ther. 1989;42:157–234. - PubMed
-
- Delomâenie C., Fouix S., Longuemaux S., Brahimi N., Bizet C., Picard B., Denamur E., Dupret J. M. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid. J. Bacteriol. 2001;183:3417–3427. - PMC - PubMed
-
- Weber W. W., Hein D. W. N-acetylation pharmacogenetics. Pharmacol. Rev. 1985;37:25–79. - PubMed
-
- Riddle B., Jencks W. P. Acetyl-coenzyme A:arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate. J. Biol. Chem. 1971;246:3250–3258. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials